This is a Validated Antibody Database (VAD) review about human KIR2DL2, based on 21 published articles (read how Labome selects the articles), using KIR2DL2 antibody in all methods. It is aimed to help Labome visitors find the most suited KIR2DL2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
KIR2DL2 synonym: CD158B1; CD158b; NKAT-6; NKAT6; p58.2; killer cell immunoglobulin-like receptor 2DL2; CD158 antigen-like family member B1; MHC class I NK cell receptor; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2; natural killer-associated transcript 6; p58 NK receptor CL-43; p58 natural killer cell receptor clone CL-43

BioLegend
mouse monoclonal (DX27)
  • flow cytometry; human; loading ...; fig 4e
BioLegend KIR2DL2 antibody (Biolegend, DX27) was used in flow cytometry on human samples (fig 4e). Cancer Immunol Immunother (2018) ncbi
mouse monoclonal (DX27)
  • flow cytometry; human; fig 1e
In order to investigate the role of Eomes in the retention of liver natural killer cells, BioLegend KIR2DL2 antibody (BioLegend, DX27) was used in flow cytometry on human samples (fig 1e). J Immunol (2016) ncbi
mouse monoclonal (DX27)
  • flow cytometry; human; loading ...; fig s1
BioLegend KIR2DL2 antibody (BioLegend, DX27) was used in flow cytometry on human samples (fig s1). J Clin Invest (2016) ncbi
mouse monoclonal (DX27)
  • flow cytometry; human; loading ...; fig 6a
BioLegend KIR2DL2 antibody (Biolegend, 312604) was used in flow cytometry on human samples (fig 6a). J Immunol (2016) ncbi
Miltenyi Biotec
mouse monoclonal (DX27)
  • flow cytometry; human; loading ...; fig s4
Miltenyi Biotec KIR2DL2 antibody (Miltenyi Biotec, DX27) was used in flow cytometry on human samples (fig s4). Front Immunol (2018) ncbi
mouse monoclonal (DX27)
  • flow cytometry; human; fig 1e
Miltenyi Biotec KIR2DL2 antibody (Miltenyi Biotec, DX27) was used in flow cytometry on human samples (fig 1e). Immun Inflamm Dis (2018) ncbi
Beckman Coulter
mouse monoclonal (GL183)
  • flow cytometry; human; loading ...; fig 3d
Beckman Coulter KIR2DL2 antibody (Beckman Coulter, GL183) was used in flow cytometry on human samples (fig 3d). J Infect Dis (2019) ncbi
mouse monoclonal (GL183)
  • flow cytometry; human; loading ...; fig s1
Beckman Coulter KIR2DL2 antibody (Beckman Coulter, GL18) was used in flow cytometry on human samples (fig s1). Eur J Immunol (2018) ncbi
mouse monoclonal (GL183)
  • flow cytometry; human; loading ...; fig 2b
Beckman Coulter KIR2DL2 antibody (Beckman Coulter, GL183) was used in flow cytometry on human samples (fig 2b). Immun Ageing (2017) ncbi
mouse monoclonal (GL183)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, Beckman Coulter KIR2DL2 antibody (Beckman Coulter, GL183) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (GL183)
  • flow cytometry; human; loading ...; fig 1c
Beckman Coulter KIR2DL2 antibody (Beckman Coulter, GL183) was used in flow cytometry on human samples (fig 1c). J Leukoc Biol (2016) ncbi
mouse monoclonal (GL183)
  • flow cytometry; human
Beckman Coulter KIR2DL2 antibody (Beckman Coulter, GL183) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (GL183)
  • flow cytometry; human
Beckman Coulter KIR2DL2 antibody (Beckman Coulter, GL183) was used in flow cytometry on human samples . Eur J Immunol (2015) ncbi
mouse monoclonal (GL183)
  • flow cytometry; human
Beckman Coulter KIR2DL2 antibody (Beckman Coulter, clone GL183) was used in flow cytometry on human samples . Mol Ther (2014) ncbi
BD Biosciences
mouse monoclonal (CH-L)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences KIR2DL2 antibody (BD Pharmingen, CH-L) was used in flow cytometry on human samples (fig 5a). Front Immunol (2019) ncbi
mouse monoclonal (CH-L)
  • flow cytometry; human; loading ...; fig 3e
BD Biosciences KIR2DL2 antibody (BD, CH-L) was used in flow cytometry on human samples (fig 3e). Front Immunol (2018) ncbi
mouse monoclonal (CH-L)
  • flow cytometry; human; loading ...; fig s2k
BD Biosciences KIR2DL2 antibody (BD Biosciences, CH-L) was used in flow cytometry on human samples (fig s2k). JCI Insight (2017) ncbi
mouse monoclonal (CH-L)
  • flow cytometry; human; fig 1e
BD Biosciences KIR2DL2 antibody (BD Biosciences, CH-L) was used in flow cytometry on human samples (fig 1e). Immun Inflamm Dis (2018) ncbi
mouse monoclonal (CH-L)
  • flow cytometry; human; loading ...; fig 6b
BD Biosciences KIR2DL2 antibody (BD, CH-L) was used in flow cytometry on human samples (fig 6b). J Immunol (2016) ncbi
mouse monoclonal (CH-L)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences KIR2DL2 antibody (BD, 559785) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (CH-L)
  • flow cytometry; human; tbl s5
In order to investigate when Vgamma9Vdelta2 T cells develop, BD Biosciences KIR2DL2 antibody (BD Bioscience, CH-L) was used in flow cytometry on human samples (tbl s5). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (CH-L)
  • flow cytometry; human
BD Biosciences KIR2DL2 antibody (BD Biosciences, CH-L) was used in flow cytometry on human samples . Biol Blood Marrow Transplant (2014) ncbi
Articles Reviewed
  1. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed publisher
  2. van Erp E, Feyaerts D, Duijst M, Mulder H, Wicht O, Luytjes W, et al. Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function. J Infect Dis. 2019;219:723-733 pubmed publisher
  3. Cooper G, Ostridge K, Khakoo S, Wilkinson T, Staples K. Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus. Front Immunol. 2018;9:1671 pubmed publisher
  4. Mahaweni N, Ehlers F, Sarkar S, Janssen J, Tilanus M, Bos G, et al. NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment. Front Immunol. 2018;9:1415 pubmed publisher
  5. Nguyen R, Houston J, Chan W, Finkelstein D, Dyer M. The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma. Cancer Immunol Immunother. 2018;67:615-626 pubmed publisher
  6. Tobin L, Mavinkurve M, Carolan E, Kinlen D, O Brien E, Little M, et al. NK cells in childhood obesity are activated, metabolically stressed, and functionally deficient. JCI Insight. 2017;2: pubmed publisher
  7. Hydes T, Noll A, Salinas Riester G, Abuhilal M, Armstrong T, Hamady Z, et al. IL-12 and IL-15 induce the expression of CXCR6 and CD49a on peripheral natural killer cells. Immun Inflamm Dis. 2018;6:34-46 pubmed publisher
  8. Chan Y, Zuo J, Inman C, Croft W, Begum J, Croudace J, et al. NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD. Eur J Immunol. 2018;48:316-329 pubmed publisher
  9. van der Geest K, Wang Q, Eijsvogels T, Koenen H, Joosten I, Brouwer E, et al. Changes in peripheral immune cell numbers and functions in octogenarian walkers - an acute exercise study. Immun Ageing. 2017;14:5 pubmed publisher
  10. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  11. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  12. Landtwing V, Raykova A, Pezzino G, Beziat V, Marcenaro E, Graf C, et al. Cognate HLA absence in trans diminishes human NK cell education. J Clin Invest. 2016;126:3772-3782 pubmed publisher
  13. Suliman S, Geldenhuys H, Johnson J, Hughes J, Smit E, Murphy M, et al. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses. J Immunol. 2016;197:1100-1110 pubmed publisher
  14. Reches A, Nachmani D, Berhani O, Duev Cohen A, Shreibman D, Ophir Y, et al. HNRNPR Regulates the Expression of Classical and Nonclassical MHC Class I Proteins. J Immunol. 2016;196:4967-76 pubmed publisher
  15. Rettman P, Willem C, David G, Riou R, Legrand N, Esbelin J, et al. New insights on the natural killer cell repertoire from a thorough analysis of cord blood cells. J Leukoc Biol. 2016;100:471-9 pubmed publisher
  16. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  17. Dimova T, Brouwer M, Gosselin F, Tassignon J, Leo O, Donner C, et al. Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire. Proc Natl Acad Sci U S A. 2015;112:E556-65 pubmed publisher
  18. Lim D, Yawata N, Selva K, Li N, Tsai C, Yeong L, et al. The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus. J Immunol. 2014;193:5065-75 pubmed publisher
  19. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed publisher
  20. Miller J, Rooney C, Curtsinger J, McElmurry R, McCullar V, Verneris M, et al. Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapy. Biol Blood Marrow Transplant. 2014;20:1252-7 pubmed publisher
  21. Ito S, Bollard C, Carlsten M, Melenhorst J, Biancotto A, Wang E, et al. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers. Mol Ther. 2014;22:1388-1395 pubmed publisher